Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
C-ROS-1 is involved in Bone marrow-derived mesenchymal stem/stromal cell fate switching between osteogenesis and adipogenesis, mediated via PI3K (show PIK3CA Proteins)/AKT (show AKT1 Proteins)/mTORC1 signalling.
Findings highlight ROS1 as a candidate biomarker and therapeutic target for oral squamous cell carcinoma.
Studies suggest that the routine clinical use of fluorescence in situ hybridization (FISH) and immunocytochemistry (ICC) may be replaced by emerging next-generation sequencing and digital, color-coded barcode technologies, which have the advantage of simultaneously evaluating anaplastic lymphoma kinase (ALK) and c-ros oncogene (show RAB1A Proteins) 1 (ROS1) and epidermal growth factor receptor (EGFR (show EGFR Proteins)) alterations in a single analysis.
ROS1-positive metastatic lung adenocarcinomas frequently harbor concomitant oncogenic driver mutations.
identified four genomic rearrangements involving the genes BRAF, RET, and ROS1
Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET (show RET Proteins)-Rearrangements in Non-Small-Cell Lung Cancer and ERG (show ERG Proteins)-Rearrangements in Prostate Cancer.(
MFA has a protective effect on alcohol-induced liver injury, which may be related to its antioxidant,anti-inflammatory,lipid-eliminating properties and its ability to regulate the NOX4 (show NOX4 Proteins)/ROS-MAPK (show MAPK1 Proteins) signalling pathway.
Female, cribriform structure and presence of psammoma body were the three most powerful indicator of ROS1 rearrangement status, and predictive formula was helpful in screening ROS1-rearranged non-small-cell lung carcinomas, especially for ROS1 immunochemistry equivocal cases.
report adds the ZCCHC8-ROS1 fusion as oncogenic driver in GBM and supports the role of ROS1 activation in the pathogenesis of a subset of glioblastoma
ROS1 mutation is associated with response to chemotherapy in lung adenocarcinoma.
GPX1-dependent alterations in oxido-reductive stress promote ROS1 activation and mediate vascular remodeling.
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.
c-ros and its ligand may be necessary for differentiation of epithelia I and II in mouse.
This proto-oncogene, highly-expressed in a variety of tumor cell lines, belongs to the sevenless subfamily of tyrosine kinase insulin receptor genes. The protein encoded by this gene is a type I integral membrane protein with tyrosine kinase activity. The protein may function as a growth or differentiation factor receptor.
c-Ros receptor tyrosine kinase
, proto-oncogene c-Ros
, proto-oncogene c-Ros-1
, proto-oncogene tyrosine-protein kinase ROS
, receptor tyrosine kinase c-ros oncogene 1
, transmembrane tyrosine-specific protein kinase
, v-ros UR2 sarcoma virus oncogene homolog 1
, v-ros avian UR2 sarcoma virus oncogene homolog 1
, Ros1 proto-oncogene
, heart - derived c - ros - 1 proto - oncogene
, proto-oncogene c-ros